Explore other Johns Hopkins Sites
Wilmer Eye Institute at Johns Hopkins
 
 
 
 
Wilmer Eye Institute
 

Ocular Citatrical Pemphigoid/Mucous Membrane Pemphigoid

Ocular Citatrical Pemphigoid/Mucous Membrane Pemphigoid

Ocular Citatrical Pemphigoid/Mucous Mebrane PemphigoidMucous Membrane Pemphigoid (MMP) is a rare, inflammatory autoimmune disorder characterized by blistering lesions that affect the mucous membranes of the body, especially the mouth and the eyes. Typical symptoms include redness, pain, tearing, and sensitivity to light. The inflammatory lesions on the ocular surface may result in scarring, loss of tear film, adhesions of the lids to the eyeball, corneal ulcers, and perforation. The frequent scarring that often occurs in this condition can lead to severe vision loss.

Diagnosis

Exact diagnosis of this condition requires a biopsy from the patient’s conjunctiva or mouth.

Treatment

The appropriate therapy MPP also includes oral immunomodulatory medications and sometimes surgical interventions. Because dry eye syndrome is often associated with MMP, dry eye therapy might be beneficial. Special gass permeable contact lenses are also beneficial.

 
 
 
 
Controversy Swirls Around Lucentis

Julia Haller, professor of ophthalmology at Johns Hopkins explains why controversy swirls around Lucentis, a new drug approved by the FDA for the treatment of macular degeneration.

About John Hopkins

Out-of-State and International Patients

 
 
 
 
 

© The Johns Hopkins University, The Johns Hopkins Hospital, and Johns Hopkins Health System, All rights reserved.

About Johns Hopkins Medicine | Patient Care | Education | Research | Health Information Library
Get Directions | Contact Us | Request an Appointment | Refer a Patient | Find a Doctor | Media Inquiries